Results 91 to 100 of about 3,152,858 (268)

Lnc-SNHG1 Activates the TGFBR2/SMAD3 and RAB11A/Wnt/β-Catenin Pathway by Sponging MiR-302/372/373/520 in Invasive Pituitary Tumors

open access: yesCellular Physiology and Biochemistry, 2018
Background/Aims: Long noncoding RNAs (lncRNAs) are critical regulators in various diseases including human cancer and could function as competing endogenous RNAs (ceRNAs) to regulate microRNAs (miRNAs).
Heyuan Wang   +7 more
doaj   +1 more source

Glioma Diagnosis Aid through CNNs and Fuzzy-C Means for MRI [PDF]

open access: yes, 2019
Glioma is a type of brain tumor that causes mortality in many cases. Early diagnosis is an important factor. Typically, it is detected through MRI and then either a treatment is applied, or it is removed through surgery.
Amaya Rodríguez, Isabel   +8 more
core  

Hypersecretion of ACTH and PRL from pituitary adenoma in MEN1, adequately managed by medical therapy

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2017
A 54-year-old man had gastrinoma, parathyroid hyperplasia and pituitary tumor. His family history indicated that he might have multiple endocrine neoplasia type 1 (MEN1). MEN1 gene analysis revealed a heterozygous germline mutation (Gly156Arg). Therefore,
Shinsuke Uraki   +7 more
doaj   +1 more source

Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism [PDF]

open access: yes, 2017
BACKGROUND: Long‐term medical management of hypersomatotropism (HS) in cats has proved unrewarding. Pasireotide, a novel somatostatin analogue, decreases serum insulin‐like growth factor 1 (IGF‐1) and improves insulin sensitivity in cats with HS when ...
Abraham   +43 more
core   +2 more sources

Metabolic profiling reveals distinct metabolic alterations in different subtypes of pituitary adenomas and confers therapeutic targets

open access: yesJournal of Translational Medicine, 2019
Background Pituitary adenomas are common brain tumors. Although transsphenoidal surgery are able to achieve extensive tumor removal, the rate of recurrence ranges from 5 to 20% depending on the different subtype.
Jie Feng   +12 more
doaj   +1 more source

Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage–tumor interaction axes among different lineages of pituitary neuroendocrine tumors

open access: yesGenome Medicine
Background Pituitary neuroendocrine tumors (PitNETs) are common gland neoplasms demonstrating distinctive transcription factors. Although the role of immune cells in PitNETs has been widely recognized, the precise immunological environment and its ...
Shaojian Lin   +24 more
doaj   +1 more source

Enhanced Performance of Brain Tumor Classification via Tumor Region Augmentation and Partition

open access: yesPLoS ONE, 2015
Automatic classification of tissue types of region of interest (ROI) plays an important role in computer-aided diagnosis. In the current study, we focus on the classification of three types of brain tumors (i.e., meningioma, glioma, and pituitary tumor ...
Jun Cheng   +7 more
semanticscholar   +1 more source

Full Issue: Volume 13, Issue 1 - Winter 2018 [PDF]

open access: yes, 2018
Full Issue: Volume 13, Issue 1 - Winter ...

core   +1 more source

Gel chromatographic characterization of immunoreactive adrenocorticotropin in patients with ACTH hypersecretion [PDF]

open access: yes, 1989
We investigated the molecular size of circulating immunoreactive ACTH by gel chromatography in patients with ACTH hypersecretion due to various disorders of the hypothalamic-pituitary-adrenal axis.
A Chatelain   +19 more
core   +1 more source

Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification

open access: yesModern Pathology, 2021
S. Asa   +28 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy